文献速递膀胱癌与上尿路尿路上皮癌

同期根治性膀胱切除术与肾输尿管切除术相关的围手术期和肿瘤学结局

Perioperative and Oncologic Outcomes Associated with Simultaneous Radical Cystectomy and Nephroureterectomy.
PubMed 文献 · Urology · 2022-11-25

本研究比较了同期根治性膀胱切除术与肾输尿管切除术(RCNU)与仅行根治性膀胱切除术(RC)的匹配队列的围手术期和肿瘤学结局。1980年至2020年间39例RCNU患者按2:1匹配74例RC患者。RCNU组总生存(OS)显著更差(HR 0.58,CI 0.35-0.97,P=0.036),而围手术期结局无显著差异。

要点

  • RCNU组总生存显著劣于RC组(HR 0.58,CI 0.35-0.97,P=0.036)。
  • 两组住院时间、估计失血量和30天并发症率无显著差异。
  • RC组手术时间显著更长。

核心结论

  • 接受RCNU的患者与匹配的仅行RC患者相比总生存显著更低。
  • 两组围手术期结局无显著差异。
  • 该数据可用于这一罕见疾病状态治疗的患者咨询。

研究设计与样本

  • 研究纳入1980年至2020年间因膀胱尿路上皮癌(UCB)和上尿路尿路上皮癌(UTUC)接受RCNU的成人患者。
  • RCNU患者按年龄(±5岁)、性别、BMI(±5)、Charlson合并症指数、病理分期(≤pT2 vs >pT2)和接受新辅助化疗情况以2:1匹配仅因UCB行RC的患者。
  • 共识别39例RCNU患者并匹配74例RC患者。

主要发现

  • 住院时间、估计失血量和30天并发症率无显著差异。
  • RC组手术时间显著更长。
  • RCNU组总生存显著更差(HR 0.58,CI 0.35-0.97,P=0.036)。
  • 无复发生存(RFS)无显著差异(HR 0.65,0.34-1.24)。
  • 癌症特异性生存(CSS)无显著差异(HR 0.58,CI 0.31-1.08,P=0.08)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To compare the perioperative and oncologic outcomes associated with RCNU to a matched cohort undergoing RC alone. Simultaneous radical cystectomy and nephroureterectomy (RCNU) for synchronous upper tract and bladder urothelial carcinoma is an uncommon procedure. Sparse literature exists comparing outcomes in patients treated with radical cystectomy (RC) alone versus RCNU. METHODS: Adults treated with RCNU for urothelial carcinoma of the bladder (UCB) and upper tract urothelial carcinoma (UTUC) between 1980 and 2020 were identified. Patients were matched 2:1 to patients undergoing RC alone for UCB based on age (+/- 5 years), gender, BMI (+/- 5), Charlson Comorbidity Index, pathologic staging (stage ≤pT2 vs >pT2), and receipt of neoadjuvant chemotherapy. Outcomes included overall survival (OS), recurrence free survival (RFS), cancer specific survival (CSS), 30-day complications, length of stay (LOS), operative time, and estimated blood loss (EBL). RESULTS: A total of 39 patients undergoing RCNU were identified and matched to 74 patients undergoing RC. There were no significant differences in LOS, EBL, or 30-day complication rates. Operative time was significantly longer in the RC cohort. OS (HR 0.58, CI 0.35-0.97, P = .036) was significantly better for patients undergoing RC alone, while no significant difference was noted in RFS (HR 0.65, 0.34-1.24) and CSS (HR 0.58, CI 0.31-1.08, P = .08). CONCLUSIONS: Patients undergoing RCNU had significantly lower OS compared to a matched group of patients undergoing RC alone. Perioperative outcomes between the groups did not differ significantly. This data can inform patient counseling for treatment of this rare disease state.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Britton CJ, Gottlich HC, Tarrell RF, et al. Perioperative and Oncologic Outcomes Associated with Simultaneous Radical Cystectomy and Nephroureterectomy. Urology. 2022. PMID: 36436677. doi:10.1016/j.urology.2022.09.039

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。